Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138577 · ClinicalTrials.gov registry record · Phase 4
Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT03138577 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants.
The verdict
NCT03138577, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This clinical trial is for subjects undergoing right upper extremity surgery. The aim of the study is to investigate the dose-response relationship between local anesthetic volume and ipsilateral hemidiaphragmatic paresis (HDP) in patients getting ultrasound-guided supraclavicular brachial plexus blocks in a blinded, prospective trial.
Interventions
- DIAGNOSTIC_TEST Ultrasound Imaging
- DRUG Supraclavicular Block
- OTHER Bedside Negative Inspiratory Force Meter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2019-07-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03138577
The ClinicalTrials.gov registry entry for NCT03138577 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ultrasound Imaging is the first listed.
NCT03138577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03138577 about?
NCT03138577 is a clinical study titled "Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block". This clinical trial is for subjects undergoing right upper extremity surgery. The aim of the study is to investigate the dose-response relationship between local anesthetic volume and ipsilateral hemidiaphragmatic paresis (HDP) in patients getting ultrasound-guided supraclavicular brachial plexus bl...
What is the current status of trial NCT03138577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2018-02-12. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03138577?
The interventions under investigation include: Ultrasound Imaging (DIAGNOSTIC_TEST), Supraclavicular Block (DRUG), Bedside Negative Inspiratory Force Meter (OTHER).
Who is sponsoring clinical trial NCT03138577?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.